sb 203580 has been researched along with octanoic acid in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (octanoic acid) | Trials (octanoic acid) | Recent Studies (post-2010) (octanoic acid) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,189 | 53 | 389 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takayama, Y; Takenouchi, T; Takezawa, T | 1 |
1 other study(ies) available for sb 203580 and octanoic acid
Article | Year |
---|---|
Co-treatment with dexamethasone and octanoate induces adipogenesis in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Caprylates; Caveolin 1; Caveolins; Cell Differentiation; Dexamethasone; Glucocorticoids; Glucose; Imidazoles; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Up-Regulation | 2004 |